Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-12 Guindo Chirfi EVP Glob. Mkt Acc & Cust Innov Grant or award · Restricted Stock Unit +10,960 10,960
2019-02-12 Gregory Ginger EVP, Human Resources Option exercise +758 1,717
2019-02-12 Gregory Ginger EVP, Human Resources Shares withheld for taxes −234 $319.43 $75K 1,483
2019-02-12 Gregory Ginger EVP, Human Resources Option exercise +1,078 2,561
2019-02-12 Gregory Ginger EVP, Human Resources Shares withheld for taxes −317 $319.43 $101K 2,244
2019-02-12 Gregory Ginger EVP, Human Resources Option exercise · Restricted Stock Unit −758 1,517
2019-02-12 Gregory Ginger EVP, Human Resources Option exercise · Restricted Stock Unit −1,078 4,602
2019-02-12 Gregory Ginger EVP, Human Resources Other disposition · Restricted Stock Unit −814 3,788
2019-02-12 Gregory Ginger EVP, Human Resources Grant or award · Restricted Stock Unit +6,890 6,890
2019-02-12 Ehlers Michael D EVP, Research and Development Option exercise +1,578 5,859.17
2019-02-12 Ehlers Michael D EVP, Research and Development Shares withheld for taxes −469 $319.43 $150K 5,390.17
2019-02-12 Ehlers Michael D EVP, Research and Development Option exercise +2,249 7,639.17
2019-02-12 Ehlers Michael D EVP, Research and Development Shares withheld for taxes −798 $319.43 $255K 6,841.17
2019-02-12 Ehlers Michael D EVP, Research and Development Option exercise · Restricted Stock Unit −1,578 3,157
2019-02-12 Ehlers Michael D EVP, Research and Development Option exercise · Restricted Stock Unit −2,249 9,591
2019-02-12 Ehlers Michael D EVP, Research and Development Other disposition · Restricted Stock Unit −1,697 7,894
2019-02-12 Ehlers Michael D EVP, Research and Development Grant or award · Restricted Stock Unit +13,460 13,460
2019-02-12 CAPELLO JEFFREY D EVP & Chief Financial Officer Grant or award · Restricted Stock Unit +12,520 12,520
2019-02-12 ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. Option exercise +1,348 26,192
2019-02-12 ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. Shares withheld for taxes −402 $319.43 $128K 25,790

Page 53 of 61 · 1,204 trades